Kromek Regulatory News (KMK)

The information contained within this announcement (the "Announcement") is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this Announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

25 February 2019

Kromek Group plc

("Kromek" the "Company" or the "Group")

Results of General Meeting and Open OfferandTotal Voting Rights 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that at the General Meeting held earlier today, all resolutions proposed were duly passed by shareholders. Furthermore, the Company announces that it has raised total gross proceeds of £1 million via the Open Offer.

The Open Offer closed for acceptances at 11.00 a.m. on 22 February 2019. The Company received valid acceptances from Qualifying Shareholders in respect of 15,317,999 Open Offer Shares, including applications for 13,302,172 Open Offer Shares under the Excess Application Facility. This represents 382 per cent. of the maximum Open Offer Shares available under the Open Offer. Accordingly, the Company has raised £21.0 million in the Placing and Open Offer and has issued and allotted 84,008,471 Placing and Open Offer Shares, conditional only on Admission becoming effective. Admission of the Placing and Open Offer Shares is expected at 8.00 a.m. on 26 February 2019.

Following Admission, the Company's issued ordinary share capital will comprise 344,559,089 Ordinary Shares, of which none are held in treasury. The above figure of 344,559,089 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the voting rights of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings as defined in the circular sent to shareholders of the Company on 7 February 2019.

For further information, please contact: